Vivos Therapeutics, Inc.
VVOS
$3.04
-$0.10-3.19%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -0.81% | -8.58% | 164.38% | 58.92% | 66.30% |
Total Receivables | -5.29% | 14.94% | -24.76% | 159.90% | -11.40% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 23.50% | 14.44% | 16.63% | -22.89% | -19.90% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.00% | -5.77% | 117.45% | 46.73% | 23.98% |
|
|||||
Total Current Assets | 1.00% | -5.77% | 117.45% | 46.73% | 23.98% |
Net Property, Plant & Equipment | -1.44% | -0.67% | -3.41% | -1.38% | -1.05% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -3.39% | -3.04% | -3.19% | -2.86% | -3.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -21.74% | 0.00% | -10.39% | 0.33% | 0.00% |
Total Assets | -0.41% | -3.12% | 34.21% | 10.01% | 4.00% |
|
|||||
Total Accounts Payable | 2.14% | -46.99% | -18.85% | 16.50% | 40.38% |
Total Accrued Expenses | 8.76% | -6.00% | -11.39% | 5.66% | 21.44% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -1.65% | 0.21% | 0.21% | 1.90% | 3.04% |
Total Finance Division Other Current Liabilities | -22.69% | -22.30% | -25.78% | 12.24% | -28.28% |
Total Other Current Liabilities | -22.69% | -22.30% | -25.78% | 12.24% | -28.28% |
Total Current Liabilities | -2.89% | -22.84% | -17.68% | 10.71% | 1.70% |
|
|||||
Total Current Liabilities | -2.89% | -22.84% | -17.68% | 10.71% | 1.70% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -10.62% | -9.53% | -8.51% | -8.02% | -7.48% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -5.79% | -11.07% | -10.33% | 16.17% | 3.36% |
Total Liabilities | -4.58% | -19.09% | -15.39% | 8.75% | 0.47% |
|
|||||
Common Stock & APIC | 2.86% | 3.74% | 7.90% | 4.21% | 5.20% |
Retained Earnings | -2.79% | -2.65% | -1.99% | -4.04% | -4.80% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 3.77% | 20.77% | 990.55% | 41.61% | 793.48% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.77% | 20.77% | 990.55% | 41.61% | 793.48% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.77% | 20.77% | 990.55% | 41.61% | 793.48% |
|